The AI Agent Quietly Transforming Hearing Care Just Secured Fresh Funding

Jan de Vries · 2026-08-28

You know that feeling when a problem seems too big and messy to solve? Well, a startup from the Netherlands just got a major vote of confidence to tackle one of healthcare's quietest, yet most pervasive, issues. Clementine, a Maastricht-based company, has closed a $2 million Seed funding round to scale its AI-powered hearing care platform. It's a significant step for a young company aiming to bridge a massive global gap. ### The Backers and Their Vision This round was led by Healthy.Capital, an Amsterdam-based early-stage HealthTech investor with a sharp eye for promising ventures. They've previously backed companies like Pharmi and OpenUp. Douwe Jippes, managing partner at Healthy.Capital, put it plainly: “Clementine combines deep domain expertise with a clear AI platform strategy that can scale globally. We believe this approach will fundamentally change how people with hearing disability engage with hearing healthcare. And that's impact we like to help scale.” That's not just investor speak; it's a recognition of a fundamental shift. ### Meet Matthew, The 24/7 Hearing Care Agent So, what exactly did they invest in? At the core of Clementine's platform is Matthew. No, not a person—an AI hearing care agent. Think of Matthew as a compassionate, infinitely patient guide who's always on duty. He engages directly with people exploring hearing care, answering questions around the clock without judgment or a waiting list. His job is to educate, overcome emotional and practical barriers, and gently guide individuals toward the appropriate next steps. For clinics drowning in calls and admin, Matthew translates inquiries into actual bookings, freeing up human staff for more complex tasks. Founder and CEO Vince van de Weijer cuts to the heart of the problem: “Clinics don't need more leads; they need better conversations at the right moment. Matthew ensures no patient inquiry goes unanswered.” It’s a simple but powerful reframe. Success isn't about volume; it's about quality of connection. ### The Staggering Scale of the Problem Let's talk about why this matters. The numbers are sobering. Hearing loss affects an estimated 1.5 billion people worldwide. Here’s the kicker: nearly 80% of those people never seek treatment. And for those who finally do? They typically wait over eight years from first noticing a problem to getting help. Eight years. That's a lifetime of missed conversations and receding connections. Clementine's approach pairs AI with behavioral science. The goal isn't to replace clinicians but to create a judgment-free, always-available entry point. It meets people where they are—often at home, on their own time, with their private concerns—long before they're ready to walk into a clinic. ### What's Next for Clementine? The timing of this funding is interesting. It comes just months after Clementine expanded its commercial reach through a partnership with Zoolstra, a marketing agency serving hearing clinics across the United States and Canada. That's a clear signal of their ambition beyond Europe. So, what will they do with $2 million? The plan is twofold: - Deepen the AI capabilities of the Matthew agent, making those conversations even more natural and effective. - Expand partnerships, not just with hearing clinics, but also with optical retailers and other healthcare organizations, creating more touchpoints for care. It’s a classic startup story of identifying a broken step in a critical process and building a smarter bridge. In a world where we automate everything from thermostats to stock trades, applying that thinking to human health and accessibility feels not just clever, but necessary. This funding round is less about the money and more about validation—that this AI-driven, human-centric approach might just be the key to unlocking care for millions who've been silently waiting.